GB201316463D0 - Novel compositions - Google Patents

Novel compositions

Info

Publication number: GB201316463D0
Authority: GB; United Kingdom
Prior art keywords: novel compositions; compositions; novel
Prior art date: 2013-09-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GB201316463A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Giles Clark & Cook Ltd

Original Assignee

Giles Clark & Cook Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-09-16

Filing date

2013-09-16

Publication date

2013-10-30

2013-09-16 Application filed by Giles Clark & Cook Ltd filed Critical Giles Clark & Cook Ltd

2013-09-16 Priority to GB201316463A priority Critical patent/GB201316463D0/en

2013-10-30 Publication of GB201316463D0 publication Critical patent/GB201316463D0/en

2013-11-08 Priority to BE2013/0761A priority patent/BE1021315B1/en

2013-11-08 Priority to IE20130342A priority patent/IE20130342A1/en

2013-11-08 Priority to PCT/EP2013/073363 priority patent/WO2015036061A1/en

2014-05-08 Priority to CA2851852A priority patent/CA2851852A1/en

2014-05-09 Priority to BR102014011184A priority patent/BR102014011184A2/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Mycology (AREA)
Microbiology (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Pharmacology & Pharmacy (AREA)
AIDS & HIV (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

GB201316463A 2013-09-16 2013-09-16 Novel compositions Ceased GB201316463D0 (en)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
GB201316463A GB201316463D0 (en)	2013-09-16	2013-09-16	Novel compositions
BE2013/0761A BE1021315B1 (en)	2013-09-16	2013-11-08	NEW COMPOSITIONS
IE20130342A IE20130342A1 (en)	2013-09-16	2013-11-08	Immunogenic compositions comprising a gp120 related polypeptide
PCT/EP2013/073363 WO2015036061A1 (en)	2013-09-16	2013-11-08	Novel compositions
CA2851852A CA2851852A1 (en)	2013-09-16	2014-05-08	Novel compositions
BR102014011184A BR102014011184A2 (en)	2013-09-16	2014-05-09	immunogenic composition, methods of treatment or prophylaxis of infection, to reduce the risk of HIV transmission, and to produce a viral composition, kit, and vector

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB201316463A GB201316463D0 (en)	2013-09-16	2013-09-16	Novel compositions

Publications (1)

Publication Number	Publication Date
GB201316463D0 true GB201316463D0 (en)	2013-10-30

Family

ID=49552735

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB201316463A Ceased GB201316463D0 (en)	2013-09-16	2013-09-16	Novel compositions

Country Status (4)

Country	Link
BE (1)	BE1021315B1 (en)
GB (1)	GB201316463D0 (en)
IE (1)	IE20130342A1 (en)
WO (1)	WO2015036061A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201621686D0 (en)	2016-12-20	2017-02-01	Glaxosmithkline Biologicals Sa	Novel methods for inducing an immune response
IE87414B1 (en)	2017-05-30	2023-07-19	Glaxosmithkline Biologicals Sa	Novel methods for manufacturing an adjuvant
MX2020005481A (en)	2017-12-01	2020-12-07	Glaxosmithkline Biologicals Sa	Saponin purification.
CN114080393A (en)	2019-06-05	2022-02-22	葛兰素史克生物有限公司	Purification of saponins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005035555A1 (en) *	2003-10-10	2005-04-21	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Hiv/siv env chimeras that promote trimerization and maintain targets of neutralizing antibodies
GB0815872D0 (en) *	2008-09-01	2008-10-08	Pasteur Institut	Novel method and compositions
EP2552480A1 (en) *	2010-03-26	2013-02-06	GlaxoSmithKline Biologicals S.A.	Hiv vaccine

2013
- 2013-09-16 GB GB201316463A patent/GB201316463D0/en not_active Ceased
- 2013-11-08 BE BE2013/0761A patent/BE1021315B1/en not_active IP Right Cessation
- 2013-11-08 WO PCT/EP2013/073363 patent/WO2015036061A1/en not_active Ceased
- 2013-11-08 IE IE20130342A patent/IE20130342A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
BE1021315B1 (en)	2015-10-28
WO2015036061A1 (en)	2015-03-19
IE20130342A1 (en)	2015-03-25

Publication	Publication Date	Title
GB201304662D0 (en)	2013-05-01	Compositions
PL3065569T3 (en)	2020-06-15	Composition
GB201608461D0 (en)	2016-06-29	Compositions
HUE044039T2 (en)	2019-09-30	Biocatalytical composition
EP3006525A4 (en)	2016-11-09	Asphalt-urethane composition
GB201319540D0 (en)	2013-12-18	Composition
GB201318489D0 (en)	2013-12-04	Composition
GB201317105D0 (en)	2013-11-06	Novel Composition
GB201320919D0 (en)	2014-01-08	Composition
GB201317388D0 (en)	2013-11-13	Composition
GB201320303D0 (en)	2014-01-01	Composition
GB201319538D0 (en)	2013-12-18	Composition
GB201306984D0 (en)	2013-05-29	Composition
GB201322772D0 (en)	2014-02-05	Composition
GB201317196D0 (en)	2013-11-13	Composition
GB201307622D0 (en)	2013-06-12	Composition
ZA201505650B (en)	2016-10-26	New compositions
GB201320962D0 (en)	2014-01-08	Compositions
GB201316463D0 (en)	2013-10-30	Novel compositions
GB201319923D0 (en)	2013-12-25	Novel composition
GB201420672D0 (en)	2015-01-07	Composition
GB201310513D0 (en)	2013-07-24	Novel composition
GB201308502D0 (en)	2013-06-19	Composition
GB201301774D0 (en)	2013-03-20	Composition
GB201318394D0 (en)	2013-12-04	Composition

Legal Events

Date	Code	Title	Description
2015-03-18	AT	Applications terminated before publication under section 16(1)